Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q3 2016 · 10-Q
Revenue$129.99M$129.99M−6.2% vs Q3 2015 Net Income-$21.19M-$21.19MN/M vs Q3 2015 EPS Diluted-$0.78-$0.78N/M vs Q3 2015 Gross Profit$12,931,000−23.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,148,000— Free Cash Flowderived-$6,808,000— Margins · derivedGross margin9.9%−2.2 pt vs Q3 2015
Operating margin-25.9%−29.4 pt vs Q3 2015
Net margin-16.3%−19.0 pt vs Q3 2015
ended Feb 28, 2016 · filed Mar 30, 2016 · 31 d after period end